SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 117 filers reported holding SANA BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $70,317,594 | -42.2% | 12,878,680 | +6.0% | 0.00% | -50.0% |
Q1 2024 | $121,551,730 | +204.1% | 12,155,173 | +24.1% | 0.00% | +100.0% |
Q4 2023 | $39,972,103 | +12.7% | 9,797,084 | +6.9% | 0.00% | 0.0% |
Q3 2023 | $35,478,554 | -34.3% | 9,167,585 | +1.2% | 0.00% | 0.0% |
Q2 2023 | $54,000,092 | +81.8% | 9,060,418 | -0.3% | 0.00% | 0.0% |
Q1 2023 | $29,710,997 | -16.1% | 9,085,932 | +1.3% | 0.00% | 0.0% |
Q4 2022 | $35,418,208 | -33.2% | 8,966,635 | +1.4% | 0.00% | -50.0% |
Q3 2022 | $53,040,000 | +2.4% | 8,839,881 | +9.8% | 0.00% | +100.0% |
Q2 2022 | $51,777,000 | -18.3% | 8,052,411 | +5.0% | 0.00% | 0.0% |
Q1 2022 | $63,351,000 | -46.9% | 7,669,682 | -0.5% | 0.00% | -66.7% |
Q4 2021 | $119,322,000 | -30.2% | 7,708,151 | +1.6% | 0.00% | -25.0% |
Q3 2021 | $170,895,000 | +253.2% | 7,588,544 | +208.3% | 0.00% | +300.0% |
Q2 2021 | $48,387,000 | -37.9% | 2,461,181 | +5.7% | 0.00% | -50.0% |
Q1 2021 | $77,906,000 | – | 2,327,607 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Trustees of Columbia University in the City of New York | 281,250 | $6,334,000 | 9.69% |
Flagship Pioneering Inc. | 34,239,018 | $771,063,000 | 8.08% |
Crestline Management, LP | 3,210,937 | $72,310,000 | 6.80% |
SB Management Ltd | 2,209,004 | $49,747,000 | 5.10% |
Omega Fund Management, LLC | 843,750 | $19,001,000 | 2.13% |
HARVARD MANAGEMENT CO INC | 1,163,601 | $26,204,000 | 1.54% |
Alphabet Inc. | 2,812,500 | $63,338,000 | 1.50% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 387,508 | $8,727,000 | 1.03% |
PUBLIC SECTOR PENSION INVESTMENT BOARD | 4,131,249 | $93,036,000 | 0.53% |
Dragoneer Investment Group | 1,500,000 | $33,780,000 | 0.44% |